Diabetic Footwear Market Report 2025

The diabetic footwear market size has grown strongly in recent years. It will grow from $8.45 billion in 2024 to $9.25 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to diabetes prevalence, aging population, diabetic foot complications, footwear comfort and support, and growing health awareness.

The diabetic footwear market size is expected to see rapid growth in the next few years. It will grow to $13.73 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to growing diabetic foot health education, footwear for active lifestyles, sustainable and eco-friendly materials, emerging market expansion, and growing non-invasive monitoring technologies. Major trends in the forecast period include personalized orthopedic footwear, technological footwear innovations, telehealth and remote consultations, technological innovations, and strategic partnerships.

The rising prevalence of diabetes is expected to drive the growth of the diabetic footwear market in the future. Diabetes is a chronic condition characterized by elevated blood glucose levels. Diabetic footwear plays a crucial role in preventing serious foot health issues associated with diabetes while offering benefits such as improved blood circulation, a wide toe box, and massaging features that alleviate pressure on pain-prone areas of the foot. For instance, in June 2023, a report from the Institute for Health Metrics and Evaluation, a US-based independent population health research organization, projected that the number of diabetics would more than double to 1.3 billion over the next 30 years. Additionally, by 2050, the total number of individuals with diabetes is anticipated to reach 529 million. Thus, the growing number of diabetic patients is fueling the expansion of the diabetic footwear market.

The diabetic footwear market is experiencing a boost due to the growing popularity of e-commerce. The rise of online platforms for buying and selling goods and services over the internet provides a global avenue for diabetic footwear manufacturers and retailers. This enables them to reach a wider audience, including individuals who may lack access to specialized physical stores. Recent data from the United States Census Bureau reveals a substantial increase in e-commerce activity, with a 7.5% growth in the second quarter of 2023 compared to the previous year. E-commerce accounted for 15.4% of all sales during this period, emphasizing its pivotal role in driving the expansion of the diabetic footwear market.

Leading companies in the diabetic footwear market are concentrating on creating innovative products, such as smart shoes, to enhance patient care and improve health outcomes. These smart shoes typically feature advanced technologies, including pressure sensors and monitoring systems, that assist in the early detection of foot problems, thereby minimizing the risk of complications like ulcers and amputations. For example, in March 2024, nine students from Oman College of Health Sciences, an educational institution based in Oman, developed a smart shoe designed to reduce complications in diabetic patients. This groundbreaking footwear aims to tackle critical health issues related to diabetes, especially diabetic foot complications, which can result in severe outcomes such as foot ulcers and amputations.

Leading companies in the diabetic footwear market are at the forefront of technological innovation, introducing advancements like smart boots tailored for diabetic patients to enhance their market performance. Smart boots are specifically engineered to aid diabetic individuals in recovering from precarious foot wounds while monitoring their adherence to rehabilitation protocols. Leveraging sensors and cloud-based technology, these boots track wear time and seamlessly share data directly with the patient's healthcare team. A notable example is Sensoria Health Inc., a US-based company specializing in smart garments and footwear for foot health monitoring. In collaboration with Defender Industries, Inc., Sensoria Health launched the Foot Defender+ powered by Sensoria smart boot for diabetics in September 2022. These boots integrate various sensors, electronics, and connectivity features to offer real-time feedback on foot temperature, pressure distribution, and other critical metrics. The overarching objective of smart boots is to proactively prevent or detect early signs of diabetic foot complications, such as ulcers or infections, safeguarding against serious health implications if left untreated.

In May 2022, Enovis, a US-based medical technology company, acquired 360 Med Care for an undisclosed amount. This acquisition is expected to enhance their surgical planning, delivery, and rehabilitation services in the global market and develop patient-specific solutions. 360 Med Care is a US-based orthopedic company that specializes in the manufacture of diabetic footwear.

Major companies operating in the diabetic footwear market include Podartis Srl Co., DJO Global Inc., Aetrex Worldwide Inc., Orthofeet Inc., Dr. Comfort llc, Drew Shoe Corp., New Balance Inc., Finn Comfort USA Inc., Diabetic Soles Inc., Hanger Inc., Hush Puppies Retail Inc., DARCO International Inc., Apex Foot Health Industries LLC, Propét USA Inc., Anodyne Shoes LLC, P.W. Minor and Son Inc., Pedorthic Shoe Company, Vionic Group LLC, San Antonio Shoe Inc., PediFix Inc., Scholl's Wellness Company LLC, Orthotic Shop Inc., Orthopedic Footwear LLC.

Diabetic footwear refers to therapeutic shoes designed for individuals with diabetes. These shoes are characterized by their broader and deeper construction compared to regular shoes, incorporating special protective inserts and soft materials. The design typically features a larger toe box to prevent squeezing of the toes and reduce the risk of bottom blisters (ulcers) caused by pressure and friction. The primary purpose of diabetic footwear is to alleviate pressure and address calluses on the bottom of the foot.

The main categories of diabetic footwear include shoes, sandals, and slippers. Diabetic shoes are crafted with special protective inserts and soft materials, aiming to enhance blood circulation, improve nerve sensation, provide a wide toe box, and offer massaging effects to alleviate pressure. These specialized footwear products are available through various distribution channels, including online platforms, specialty stores, and traditional footwear stores. Diabetic footwear caters to diverse end-users, including men and women.

The diabetic foot wear market research report is one of a series of new reports that provides diabetic foot wear market statistics, including global market size, regional shares, competitors with a diabetic foot wear market share, detailed diabetic foot wear market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic foot wear industry. This diabetic foot wear market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

North America was the largest region in the diabetic footwear market in 2024. The regions covered in the diabetic footwear market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the diabetic footwear market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The diabetic footwear market consists of sales of in-depth shoes, healing shoes, and custom-made shoes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.